VONOFLIT 20 contains Vonoprazan 20 mg, a modern potassium-competitive acid blocker formulated for potent control of gastric acid-related disorders. A differentiated PCD Pharma Gastro portfolio product.
Acid-related disorders including GERD and peptic ulcer disease, depending on prescription.
It provides potent potassium-competitive acid blockade.
Take exactly as prescribed. Inform the physician about prolonged symptoms, liver disease or other medicines. Long-term therapy should be medically reviewed.
Headache, diarrhea, constipation, abdominal discomfort and nausea may occur.
VONOFLIT 20: Vonoprazan blocks the gastric H+/K+-ATPase through potassium-competitive acid blockade, providing potent and sustained suppression of gastric acid secretion.
